| Title : Activation of acetylcholinesterase after U-74389G administration in a porcine model of intracerebral hemorrhage - Bimpis_2012_Metab.Brain.Dis_27_221 |
| Author(s) : Bimpis A , Papalois A , Tsakiris S , Zarros A , Kalafatakis K , Botis J , Stolakis V , Zissis KM , Liapi C |
| Ref : Metabolic Brain Disease , 27 :221 , 2012 |
| Abstract : Spontaneous intracerebral hemorrhage (ICH) accounts for 10-15% of all strokes. Despite high incidence, morbidity and mortality, the precise pathophysiology of spontaneous ICH is not fully understood, while there is little data concerning the mechanisms that follow the primary insult of the hematoma formation. The cholinergic system, apart from its colossal importance as a neurotransmission system, seems to also play an important role in brain injury recovery. It has been recently suggested that the brain possesses a cholinergic anti-inflammatory pathway that counteracts the inflammatory responses after ICH, thereby limiting damage to the brain itself. We, herein, report the findings of our study concerning the role of acetylcholinesterase (AChE; a crucial membrane-bound enzyme involved in cholinergic neurotransmission) in a porcine model of spontaneous ICH, with a focus on the first 4 and 24 h following the lesion's induction, in combination with a study of the effectiveness of the lazaroid antioxidant U-74389G administration. Our study demonstrates the activation of AChE activity following U-74389G administration. The lazaroid U-74389G seems to be an established neuroprotectant and this is the first report of its supporting role in the enhancement of cholinergic response to the induction of ICH. |
| ESTHER : Bimpis_2012_Metab.Brain.Dis_27_221 |
| PubMedSearch : Bimpis_2012_Metab.Brain.Dis_27_221 |
| PubMedID: 22476954 |
Bimpis A, Papalois A, Tsakiris S, Zarros A, Kalafatakis K, Botis J, Stolakis V, Zissis KM, Liapi C (2012)
Activation of acetylcholinesterase after U-74389G administration in a porcine model of intracerebral hemorrhage
Metabolic Brain Disease
27 :221
Bimpis A, Papalois A, Tsakiris S, Zarros A, Kalafatakis K, Botis J, Stolakis V, Zissis KM, Liapi C (2012)
Metabolic Brain Disease
27 :221